Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia

A novel niosomal delivery system was designed and investigated for the targeted delivery of daunorubicin (DNR) against acute myeloid leukemia (AML). Anti-CD123 antibodies conjugated to Mal-PEG(2000)-DSPE were incorporated into normal niosomes (NS) via a post insertion method to afford antibody-modif...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Drug Deliv
मुख्य लेखकों: Liu, Fu-rong, Jin, Hui, Wang, Yin, Chen, Chen, Li, Ming, Mao, Sheng-jun, Wang, Qiantao, Li, Hui
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Taylor & Francis 2017
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8244627/
https://ncbi.nlm.nih.gov/pubmed/28574300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2017.1333170
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन